SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950103-19-002275
Filing Date
2019-02-25
Accepted
2019-02-25 06:00:55
Documents
7
Period of Report
2019-02-22
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dp102568_8k.htm 8-K 25838
2 EXHIBIT 99.1 dp102568_ex9901.htm EX-99.1 10944
3 EXHIBIT 99.2 dp102568_ex9902.htm EX-99.2 11899
4 EXHIBIT 99.3 dp102568_ex9903.htm EX-99.3 37721
5 EXHIBIT 99.4 dp102568_ex9904.htm EX-99.4 40713
6 GRAPHIC image_001.jpg GRAPHIC 2902
7 GRAPHIC image_002.jpg GRAPHIC 2804
  Complete submission text file 0000950103-19-002275.txt   136681
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 19627959
SIC: 2834 Pharmaceutical Preparations